Get the Stockscreener App
4.70
4.44%
0.20
After Hours:
4.71
0.010
+0.21%
Aurora Cannabis Inc. stock is traded at $4.70, with a volume of 798.68K.
It is up +4.44% in the last 24 hours and up +6.58% over the past month.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
See More
Previous Close:
$4.50
Open:
$4.53
24h Volume:
798.68K
Relative Volume:
0.86
Market Cap:
$257.92M
Revenue:
$195.82M
Net Income/Loss:
$-88.78M
P/E Ratio:
-1.8733
EPS:
-2.5089
Net Cash Flow:
$-88.86M
1W Performance:
+9.30%
1M Performance:
+6.58%
6M Performance:
-4.08%
1Y Performance:
-1.18%
1-Day Range:
$4.47
$4.71
1-Week Range:
$4.0638
$4.71
52-Week Range:
$2.84
$9.35
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
4.70 | 257.92M | 195.82M | -88.78M | -88.86M | -2.5089 |
|
ZTS
Zoetis Inc
|
163.31 | 73.68B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.46 | 42.77B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.26 | 42.04B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.24 | 24.07B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.28 | 14.66B | 15.05B | -883.30M | 1.89B | -0.74 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-24 | Initiated | TD Cowen | Buy |
| Feb-09-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Aurora Cannabis Inc. stock rises Friday, outperforms market - MarketWatch
Aurora Cannabis Inc. stock rises Thursday, outperforms market - MarketWatch
Watch These Marijuana Stocks Push Their Limits On Tuesday (2/5/19) - AccessWire
Aurora Cannabis Inc. stock rises Tuesday, outperforms market - MarketWatch
Aurora Cannabis Well Positioned For International Cannabis Markets (NASDAQ:ACB) - Seeking Alpha
Better Marijuana Stock: Aurora Cannabis or Tilray Brands? - AOL
Aurora Cannabis Inc. stock outperforms market despite losses on the day - MarketWatch
Is Aurora Cannabis Inc. (ACB) the Best Marijuana Stock to Buy According to Hedge Funds? - Insider Monkey
10 Best Marijuana Stocks To Buy According to Hedge Funds - Insider Monkey
Aurora Cannabis Inc. stock falls Tuesday, underperforms market - MarketWatch
Aurora Cannabis Inc. stock rises Monday, still underperforms market - MarketWatch
Cannabis Extract Market Set to Witness Significant Growth by 2024-2031:Aurora Cannabis Inc, Tikun Olam,Tilray - EIN News
Aurora Cannabis (ACB) Stock Surges Amid Market Activity - GuruFocus.com
Cannabis Cultivation Market Set to Witness Significant Growth by 2024-2031: Aphria, Inc., Aurora Cannabis, - EIN News
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Aurora Cannabis Q3 EPS Estimate Reduced by Atb Cap Markets - MarketBeat
Better Marijuana Stock: Aurora Cannabis Or Tilray Brands? - Barchart
Atb Cap Markets Comments on Aurora Cannabis Q3 Earnings - MarketBeat
Aurora Cannabis Inc. stock falls Wednesday, underperforms market - MarketWatch
Stocks In Play: Aurora Cannabis Inc. - Barchart
Aurora announces distribution partnership between MedReleaf Australia and The Entourage Effect - StratCann
Aurora Cannabis (TSE:ACB) Price Target Cut to C$8.50 by Analysts at ATB Capital - MarketBeat
Aurora Cannabis Inc. - Baystreet.ca
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect - PR Newswire
Aurora Cannabis Inc. stock falls Monday, underperforms market - MarketWatch
Why Aurora Cannabis (ACB) Is Among the Best Cannabis Stocks To Invest In? - Yahoo Finance
11 Best Cannabis Stocks To Invest In - Insider Monkey
Aurora Cannabis (TSE:ACB) Upgraded to "Strong-Buy" at TD Securities - MarketBeat
Aurora Cannabis (NASDAQ:ACB) Upgraded at TD Securities - MarketBeat
Aurora Cannabis Inc. stock rises Monday, outperforms market - MarketWatch
Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting - Longview News-Journal
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand - Benzinga
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold? - Benzinga
Cannabidiol Market Set to Witness Significant Growth by 2024-2031: Isodiol International Inc., Aurora Cannabis - EIN News
Aurora Cannabis (TSE:ACB) Trading Down 4.6%Should You Sell? - MarketBeat
Aurora Cannabis Inc. stock rises Friday, still underperforms market - MarketWatch
Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Update - MarketBeat
Marijuana Cigarette Market to See Huge Growth by 2030: Curaleaf , Aurora Cannabis - openPR
Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans - Benzinga
Aurora Cannabis Inc (ACB-T) QuotePress Release - The Globe and Mail
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility - Barchart
Aurora Cannabis Expands Medical Portfolio with 5 New Premium Cannabis Products - StockTitan
Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump - Simply Wall St
German Cannabis: 20 Tons, 10M GramsAnd That's Only 0.3% Of The Market, What's Missing? - Benzinga
Aurora Cannabis expands product lineup with new flavors By Investing.com - Investing.com Australia
Aurora Cannabis Inc. Stock (ACB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
2.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):